Market news

In July 2026, Akso Health Group reported full-year results for the period ended March 31, 2026, showing sales of US$13.84 million and a net loss of US$18.67 million, alongside materially lower loss per share than a year earlier. On the same date, auditor CHI-LLTC issued an unqualified opinion but raised substantial doubt about Akso Health Group’s ability to continue as a going concern, highlighting serious questions about its financial resilience despite narrowed losses. We’ll now examine...